» Download Public Reports
About 300 reports
- Country report
- March 2013
- 5 pages
- by Corporation
... With the new care concepts; - new market segments, such as homes, are evolving. Multiple changes in the swiss market pharmacy consolidation; suboptimal locations under pressure Growth of pharmacy ...
December 2012
... To build on the long-term success of herceptin as the standard of care for women with her2-positive metastatic breast cancer, a particularly aggressive form of the disease. The pipeline remained robust ...
December 2012
... Investments will receive around usd 4 million in several tranches up to 2014. Further payments of up to usd 7 million will fall due upon the approval of the aeroquintm antibiotic in europe and in the usa ...
December 2012
... B , fabian heimscha , giuliano masierob,c antibiotic consumption and dispensing physicians background developed countries: prescribe without dispensing avoid con Ict of interest and ensure good practice (trap ...
January 2013
... Of changes to core operating profit margins. 2 International financial reporting standards (ifrs) results include special items such as restructuring. 2/17 Helps women with her2-positive breast cancer ...
February 2013
... In moderate to high risk people to prevent strokes and heart attacks Secondary prevention of strokes and heart attacks Cancer - cervical cancer and hepatitis b immunization best buys How do you ...
» Purchase Premium Reports
(From $ 125 - $ 1 088)
About 200 reports
- $ 1 088
- Industry report
- May 2013
- by Business Monitor International
BMI View: The expected growth of the Switzerland's ageing population over the next 50 years will have an unprecedented impact on the demand for healthcare. The elderly require more medical check-ups and ...
April 2013
$ 750
Summary Kuros Biosurgery AG (Kuros) is a medical technology company.The company develops injectable biomaterial products for the trauma and wound care markets. It was formed as a spin-off from the Swiss ...
April 2013
$ 750
Summary Sensile Medical AG (Sensile Medical) is a privately held medical device company, which researches and develops nanoliter based medical devices for the treatment of diabetes. It focuses on the development ...
May 2013
$ 750
Summary Debiotech S.A. (Debiotech) is a medical device company. The company develops therapeutic devices and diagnostic products. It operates through its product categories such as Electronic Infusion ...
March 2013
$ 300
Summary Zambon Company S.p.A. (Zambon), the holding company of the Zambon Group, is a major multinational pharmaceutical and chemical company. It develops, manufactures and markets specialized pharmaceuticals ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
March 2013
$ 300
Summary ARKOPHARMA Laboratories (Arkopharma) is phytotherapy and nutritional supplements provider in Europe, engaged in the manufacture and distribution of pharmaceutical products. Its product portfolio ...